Kanayama N et al. |
Drug-drug interactions in the metabolism of imidafenacin: role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymes. |
2007 |
Xenobiotica |
pmid:17484517
|
Altintas E et al. |
Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori. |
2004 |
World J. Gastroenterol. |
pmid:15162544
|
Cosme A et al. |
Antimicrobial susceptibility testing before first-line treatment for infection in patients with dual or triple antibiotic resistance. |
2017 |
World J. Gastroenterol. |
pmid:28566898
|
Choi HS et al. |
Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection. |
2012 |
World J. Gastroenterol. |
pmid:22654429
|
Si JM et al. |
Quality of gastric ulcer healing evaluated by endoscopic ultrasonography. |
2005 |
World J. Gastroenterol. |
pmid:15948255
|
Hagiwara T et al. |
Improvement in symptoms after H2-receptor antagonist-based therapy for eradication of H pylori infection. |
2007 |
World J. Gastroenterol. |
pmid:17657838
|
Kawakami E et al. |
Furazolidone-based triple therapy for H pylori gastritis in children. |
2006 |
World J. Gastroenterol. |
pmid:17006997
|
Sanches BS et al. |
Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: A national survey. |
2016 |
World J. Gastroenterol. |
pmid:27672279
|
Gumurdulu Y et al. |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey. |
2004 |
World J. Gastroenterol. |
pmid:14991935
|
Ahmad N et al. |
Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pylori. |
2009 |
World J. Gastroenterol. |
pmid:19575497
|
Guo CY et al. |
Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection. |
2004 |
World J. Gastroenterol. |
pmid:14991953
|
Mirbagheri SA et al. |
Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial. |
2006 |
World J. Gastroenterol. |
pmid:16937475
|
Luo XF et al. |
Establishment of a nested-ASP-PCR method to determine the clarithromycin resistance of Helicobacter pylori. |
2016 |
World J. Gastroenterol. |
pmid:27433095
|
Ching SS et al. |
Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital. |
2008 |
World J. Gastroenterol. |
pmid:18609709
|
Miehlke S et al. |
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). |
2001 |
World J. Gastroenterol. |
pmid:11819768
|
Trifan A et al. |
Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication. |
2013 |
World J. Gastroenterol. |
pmid:24259981
|
Sun QJ et al. |
Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai. |
2010 |
World J. Gastroenterol. |
pmid:20976850
|
Chuah SK et al. |
A new look at anti-Helicobacter pylori therapy. |
2011 |
World J. Gastroenterol. |
pmid:22046084
|
Matta AJ et al. |
Punctual mutations in gene of clarithromycin-resistant in Colombian populations. |
2018 |
World J. Gastroenterol. |
pmid:29662291
|
Buzás GM and Józan J |
First-line eradication of H pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2004. |
2006 |
World J. Gastroenterol. |
pmid:16981260
|
Chen SJ et al. |
Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients. |
2008 |
World J. Gastroenterol. |
pmid:18350632
|
Sargýn M et al. |
Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori. |
2003 |
World J. Gastroenterol. |
pmid:12717872
|
Abadi ATB |
Resistance to clarithromycin and gastroenterologist's persistence roles in nomination for Helicobacter pylori as high priority pathogen by World Health Organization. |
2017 |
World J. Gastroenterol. |
pmid:29085187
|
Lai YC et al. |
Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers. |
2004 |
World J. Gastroenterol. |
pmid:15052680
|
Ji F et al. |
Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial. |
2006 |
World J. Gastroenterol. |
pmid:16586550
|
Molina-Infante J and Gisbert JP |
Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance. |
2014 |
World J. Gastroenterol. |
pmid:25132750
|
Cianci R et al. |
Third-line rescue therapy for Helicobacter pylori infection. |
2006 |
World J. Gastroenterol. |
pmid:16688818
|
Sereni G et al. |
Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection. |
2012 |
World J. Gastroenterol. |
pmid:22969227
|
Isomoto H et al. |
Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin. |
2005 |
World J. Gastroenterol. |
pmid:15786539
|
Wang HH et al. |
One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy. |
2005 |
World J. Gastroenterol. |
pmid:15786549
|
Aydemir S et al. |
Helicobacter pylori infection in hemodialysis patients: susceptibility to amoxicillin and clarithromycin. |
2005 |
World J. Gastroenterol. |
pmid:15682477
|
O'Morain C |
Role of Helicobacter pylori in functional dyspepsia. |
2006 |
World J. Gastroenterol. |
pmid:16718752
|
Shimbo I et al. |
Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy. |
2005 |
World J. Gastroenterol. |
pmid:16437727
|
Wang CH et al. |
Effects of daily telephone-based re-education before taking medicine on Helicobacter pylori eradication: A prospective single-center study from China. |
2015 |
World J. Gastroenterol. |
pmid:26494972
|
Sugimoto M and Furuta T |
Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype. |
2014 |
World J. Gastroenterol. |
pmid:24914361
|
Heo J and Jeon SW |
Optimal treatment strategy for Helicobacter pylori: era of antibiotic resistance. |
2014 |
World J. Gastroenterol. |
pmid:24914324
|
Sun WH et al. |
Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of Helicobacter pylori in Chinese peptic ulcer patients. |
2005 |
World J. Gastroenterol. |
pmid:15832421
|
Wu IT et al. |
Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan. |
2015 |
World J. Gastroenterol. |
pmid:26457027
|
Yilmaz O and Demiray E |
Clinical role and importance of fluorescence in situ hybridization method in diagnosis of H pylori infection and determination of clarithromycin resistance in H pylori eradication therapy. |
2007 |
World J. Gastroenterol. |
pmid:17278188
|
Zhao LJ et al. |
Helicobacter pylori isolates from ethnic minority patients in Guangxi: resistance rates, mechanisms, and genotype. |
2014 |
World J. Gastroenterol. |
pmid:24782630
|
Mohammadi M et al. |
Helicobacter pylori antibiotic resistance in Iran. |
2005 |
World J. Gastroenterol. |
pmid:16273615
|
Nishida T et al. |
Comparative study of esomeprazole and lansoprazole in triple therapy for eradication of Helicobacter pylori in Japan. |
2014 |
World J. Gastroenterol. |
pmid:24764674
|
Sakurai K et al. |
Comparative study: Vonoprazan and proton pump inhibitors in eradication therapy. |
2017 |
World J. Gastroenterol. |
pmid:28216974
|
Onyekwere CA et al. |
Rabeprazole, clarithromycin, and amoxicillin Helicobacter pylori eradication therapy: report of an efficacy study. |
2014 |
World J. Gastroenterol. |
pmid:24707145
|
Wu JY et al. |
Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests. |
2014 |
World J. Gastroenterol. |
pmid:24695835
|
Gao XZ et al. |
Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication. |
2010 |
World J. Gastroenterol. |
pmid:20818821
|
Mabe K et al. |
Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer? |
2009 |
World J. Gastroenterol. |
pmid:19750572
|
Farshad S et al. |
Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran. |
2010 |
World J. Gastroenterol. |
pmid:21128326
|
Riquelme A et al. |
Optimal length of triple therapy for H pylori eradication in a population with high prevalence of infection in Chile. |
2007 |
World J. Gastroenterol. |
pmid:17589948
|
Ersoy O et al. |
H pylori infection in patients with Behcet's disease. |
2007 |
World J. Gastroenterol. |
pmid:17589951
|